Catalyst Pharmaceutical Partners Inc buy Truist Financial Co.
Start price
09.08.24
/
50%
€16.68
Target price
09.08.25
€27.48
Performance (%)
1.02%
End price
10.08.25
€16.85
Summary
This prediction ended on 10.08.25 with a price of €16.85. The BUY prediction by Truist_Financial_Co_ finished with a performance of 1.02%. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | -0.396% | -0.396% | -1.324% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its price target raised by analysts at Truist Financial Co. from $25.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for CPRX provided by MarketBeat
In the thread Trading Catalyst Pharmaceutical Partners Inc
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Truist_Financial_Co_ for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€22.00
11.11.24
11.11.24
€33.80
11.11.25
11.11.25
-10.57%
12.11.25
12.11.25
